BiologicalDrug
Cytokine-induced killer cell clinical trials
Also written CIK cells.
- studies test it
- 10
- open now
- 0
- in phase 3
- 2
- first study started
- 2006
How studies write it
Studies that test it under each name
Other names
Combined with it in one product
Studies by the year they started
10 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 8
- Phase 3
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 8
People's Hospital of Guangxi (2) · LucasBio (1) · Tianjin Medical University Cancer Institute and Hospital (1) · Everett Meyer (1) · Sally Arai (1) · Kunming Medical University (1) · Peter Bader (1) · Sabz Biomedicals (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses cytokine-induced killer cell is read from its arms, and is right about nine times in ten.
Testing it · 10
- Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant Recipients.CompletedNot applicableLucasBioNCT07692607Written as CIK cells
- CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT.Status unknownPhase 1/2Peter BaderNCT02752243Written as CIK-Cells
- Autologous Killer Cell Therapy in Colon Cancer PatientsStatus unknownPhase 1/2Sabz BiomedicalsNCT03329664Written as Cytokine-induced killer cell
- Study of Chemotherapy Combination With Autologous Cytokine-Induced Killer Cell Immunotherapy to Treat Lung CancerCompletedPhase 2/3Tianjin Medical University Cancer Institute and HospitalNCT01631357Written as CIK cell
- Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative DisordersCompletedPhase 2Everett MeyerNCT01392989Written as CIK cells
- Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic MalignanciesCompletedPhase 1Sally AraiNCT00477035Written as CIK cells
- Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell LymphomasStatus unknownPhase 1/2Han weidongNCT01799083Written as cytokine-induced killer cell
- CIK Cell Transfusion Plus Gefitinib As Second Or Third-Line Treatment for Advanced Adenocarcinoma Non-Small Cell Lung CancerTerminatedPhase 2Kunming Medical UniversityNCT01871480Written as Group A:cytokine-induced killer cell +gefitinib
- Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Small Cell Lung CancerStatus unknownPhase 2People's Hospital of GuangxiNCT01592422Written as Autologous cytokine-induced killer cell
- Maintenance Therapy With Autologous Cytokine-induced Killer Cells for Nonsquamous Non-small Cell Lung CancerStatus unknownPhase 2/3People's Hospital of GuangxiNCT01481259Written as Autologous cytokine-induced killer cell
Given in every arm · 2 — cytokine-induced killer cell is usual care beside what is tested
- Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung CancerActive, not recruitingPhase 2Tianjin Medical University Cancer Institute and HospitalNCT04836728Written as CIK cells injection
- Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell CarcinomaStatus unknownPhase 2Tianjin Medical University Cancer Institute and HospitalNCT03987698Written as CIK cells